WuXi AppTec Co Ltd (603259) Habari na Bei kuhusu Hisa

Kwa nini 603259 imepungua kwa 6.60%?

Fahamu zaidi

603259:SHA

WuXi AppTec Co Ltd

CN¥ 144.30

-6.60%

(-10.20) Siku 1

16 Okt, 15:00:01 GMT +8 · CNY

Alama zote

	Alama	Bei	Tofauti	Tofauti ya asilimia

Inatayarisha maarifa maarufu ya 603259...

Fungua

CN¥ 156.94

Juu

CN¥ 159.92

Chini

CN¥ 139.05

Mtaji wa soko

447.48B

Wastani wa kiasi cha mauzo

34.02M

Kiasi cha mauzo ya hisa

83.61M

Gawio

1.45%

Mgawo wa faida wa kila robo mwaka

CN¥ 0.52

Tarehe ya kutojumuisha gawio

4 Sep 2026

Uwiano wa bei ya hisa na mapato kwa kila hisa

19.63

Juu kwa wiki 52

CN¥ 173.60

Chini kwa wiki 52

CN¥ 87.09

EPS

CN¥ 7.35

Hisa za wawekezaji

1.05B

Idadi ya wafanyakazi

elfu 36

Fungua

CN¥ 156.94

Juu

CN¥ 159.92

Chini

CN¥ 139.05

Mtaji wa soko

447.48B

Wastani wa kiasi cha mauzo

34.02M

Kiasi cha mauzo ya hisa

83.61M

Gawio

1.45%

Mgawo wa faida wa kila robo mwaka

CN¥ 0.52

Tarehe ya kutojumuisha gawio

4 Sep 2026

Uwiano wa bei ya hisa na mapato kwa kila hisa

19.63

Juu kwa wiki 52

CN¥ 173.60

Chini kwa wiki 52

CN¥ 87.09

EPS

CN¥ 7.35

Hisa za wawekezaji

1.05B

Idadi ya wafanyakazi

elfu 36

Hisa zinazohusiana

FuYao Glass Industry Group Ord Shs A

CN¥ 54.78

+0.48%

600900

China Yangtze Power Co., Ltd.

CN¥ 29.38

-0.74%

600547

Shandong Gold Mining Co Ltd

CN¥ 26.37

+3.78%

Habari

Kutoka kwenye vyanzo vya wavuti na washirika wa habari

ad-hoc-news.de

siku 1 iliyopita

Morgan Stanley keeps target for WuXi AppTec stock at HKD 207.40

ad-hoc-news.de

siku 2 zilizopita

Morgan Stanley backs 800-ton expansion for WuXi AppTec stock

Wasifu

WuXi AppTec Co., Ltd. is a Chinese provider of contract research, development, and manufacturing, services for the pharmaceutical and life-sciences industry, headquartered in Shanghai, China. The company operates research and manufacturing facilities in Asia, North America, and Europe. Founded in 2000 by chemist Ge Li as WuXi PharmaTech, the company expanded through acquisitions and re‑listings in 2018 after a 2015 take‑private. It produces a large part of the ingredients used in treatments for illnesses including leukemia, lymphoma, HIV, and obesity. As of 2025, the company reported around 39,000 employees and 6,000 customers. Its clients have included Jiangsu Hengrui, GlaxoSmithKline, AstraZeneca and Pfizer. Wikipedia

Kuhusu WuXi AppTec Co Ltd

Afisa Mkuu Mtendaji (CEO)Steve Yang | Ge Li

Wafanyakazielfu 35.6

Lilianzishwa1 Des 2000

Makao makuu-

Sekta-

Tovutiwuxiapptec.com.cn

Thamani zote katika CNY	Sep 2025	Des 2025	Mac 2026	Jun 2026
Mapato	12.04B	10.97B	12.44B	16.46B
Gharama ya bidhaa zilizouzwa	6.07B	4.91B	6.17B	-
Gharama ya mapato	6.07B	4.91B	6.17B	-
Gharama za utafiti na maendeleo	311.73M	236.94M	266.96M	-
Jumla ya gharama za utafiti na maendeleo	-	-	-	-
Gharama za uuzaji, za jumla na za usimamizi	854.49M	853.67M	891.80M	-
Gharama ya uendeshaji	1.38B	1.26B	1.22B	-
Jumla ya gharama za uendeshaji	7.45B	6.17B	7.39B	-
Mapato ya uendeshaji	4.59B	4.80B	5.04B	-
Mapato mengine yasiyo ya uendeshaji	-470.36M	281.37M	-266.37M	-
EBT ikijumuisha vipengee visivyo vya kawaida	5.13B	6.75B	5.61B	-
EBT bila kujumuisha vipengee visivyo vya kawaida	5.11B	6.95B	5.19B	-
Gharama ya kodi ya mapato	1.55B	1.09B	936.77M	-
Kiwango cha kodi kinachotumika	30.19%	16.12%	16.71%	-
Gharama nyingine za uendeshaji	57.96M	25.84M	elfu 726.05	-
Mapato halisi	3.51B	7.08B	4.65B	-
Kiwango cha faida halisi	29.18%	64.49%	37.40%	-
Mapato kwa kila hisa	1.24	1.42	1.57	2.20
Mapato ya riba na uwekezaji	1.21B	1.87B	439.82M	-
Gharama ya riba	-226.71M	-	-30.95M	-
Jumla ya gharama halisi za riba	981.72M	1.87B	408.87M	-
Gharama za kushuka kwa thamani na za kulipa deni	-	-	-	-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni	5.21B	5.61B	5.85B	-
Faida au hasara kutokana na uuzaji wa vipengee	-158.03M	218.40M	-	-

Fedha

Uliza chochote